Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions

Scand J Respir Dis Suppl. 1973;84:119-24.
No abstract available

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Adolescent
  • Cycloserine / therapeutic use
  • Drug Therapy, Combination
  • Dyspnea / chemically induced
  • Ethambutol / administration & dosage
  • Ethambutol / therapeutic use
  • Ethionamide / therapeutic use
  • Fever / chemically induced
  • Follow-Up Studies
  • Headache / chemically induced
  • Humans
  • Purpura, Thrombocytopenic / chemically induced
  • Pyrazinamide / therapeutic use
  • Rifampin / administration & dosage
  • Rifampin / adverse effects*
  • Rifampin / therapeutic use
  • Time Factors
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Pyrazinamide
  • Ethambutol
  • Cycloserine
  • Ethionamide
  • Rifampin